Encompass Health (EHC) to Release Earnings on Thursday

Encompass Health (NYSE:EHC) will likely be announcing its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect the company to announce earnings of $1.29 per share and revenue of $1.5403 billion for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Friday, February 6, 2026 at 10:00 AM ET.

Encompass Health Price Performance

Encompass Health stock opened at $93.76 on Tuesday. The stock has a market capitalization of $9.43 billion, a P/E ratio of 17.72, a P/E/G ratio of 1.52 and a beta of 0.74. The company’s fifty day moving average price is $105.66 and its 200 day moving average price is $114.79. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.14. Encompass Health has a 1 year low of $92.53 and a 1 year high of $127.99.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of EHC. Alliancebernstein L.P. lifted its holdings in shares of Encompass Health by 6.8% in the 2nd quarter. Alliancebernstein L.P. now owns 2,039,314 shares of the company’s stock worth $250,081,000 after acquiring an additional 129,276 shares during the last quarter. Raymond James Financial Inc. lifted its stake in Encompass Health by 34.8% during the third quarter. Raymond James Financial Inc. now owns 1,541,336 shares of the company’s stock worth $195,780,000 after purchasing an additional 397,694 shares in the last quarter. Millennium Management LLC boosted its holdings in Encompass Health by 140.0% during the 3rd quarter. Millennium Management LLC now owns 1,223,665 shares of the company’s stock valued at $155,430,000 after acquiring an additional 713,738 shares during the period. Franklin Resources Inc. grew its position in Encompass Health by 4.1% in the 3rd quarter. Franklin Resources Inc. now owns 1,074,044 shares of the company’s stock valued at $136,425,000 after acquiring an additional 42,596 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its stake in Encompass Health by 3.4% during the third quarter. Arrowstreet Capital Limited Partnership now owns 1,067,389 shares of the company’s stock worth $135,580,000 after purchasing an additional 34,919 shares during the period. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on EHC shares. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Finally, Barclays boosted their price target on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research report on Thursday, October 30th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $142.86.

About Encompass Health

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.